// App-Quantinova.ai

S1054 2016 AHA : Novel Atheroprotection Therapy: Reduction in Serum Lipid Levels by HSP27 Via Down-regulation of HNF1a and PCSK9 Expression

Researchers

Presenter

  • Yong-Xiang Chen

Principal Investigators

  • Catherine Diao

  • Zarah Batulan

  • Edward R OBrien

Medical Centers

  • Libin Cardiovascular Inst of Alberta / Cumming Sch of Med/ Univ of Calgary, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Dyslipidemia

Biomarkers

  • Nucleoside diphosphate kinase A

  • Proprotein convertase subtilisin/kexin type 9

  • Heat shock protein 27

Drug/Treatment

  • Atorvastatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved